上海生物制品研究所导师介绍：陈则

　　GuoLina,ZhengMei,DingYahong,LiDongmei,YangZhongdong,WangHaiming,ChenQuanjiao,SuiZhiwei,FangFangandChenZe*.ProtectionagainstmultipleinfluenzaAsubtypesbyintranasaladministrationofrecombinantnucleoprotein.ArchVirol.2010Nov;155(11):1765-75.
　　ChenJ,HuangS,ChenZ*.HumancellularproteinnucleoporinhNup98interactswithinfluenzaAvirusNS2/NEPproteinandover-expressionofitsGLFGrepeatdomaincaninhibitviruspropagation.JGenVirol.2010Oct;91(Pt10):2474-84.
　　ChangH,LiX,TengY,LiangY,PengB,FangF,ChenZ*.ComparisonofAdjuvantEfficacyofChitosanandAluminumHydroxideforIntraperitoneallyAdministeredInactivatedInfluenzaH5N1Vaccine.DNACellBiol.2010Sep;29(9):563-8.
　　ZeChen*,ZhongdongYang.PandemicInfluenzaVaccineClinicalTrialAbstractMinimumInformation:SummaryonH1N1vaccineinChina:statemanufacturers.publishedontheWorldHealthOrganization(WHO)website(http://www.who.int/entity/vaccine_research/diseases/influenza/18_feb_ZeChen.pdf)2010，
　　LuB,HuangY,HuangL,LiB,ZhengZ,ChenZ,ChenJ,HuQ,WangH.Effectofmucosalandsystemicimmunizationwithvirus-likeparticlesofsevereacuterespiratorysyndromecoronavirusinmice.Immunology.2010Jun;130(2):254-61.
　　WuJ,ZhangF,FangF,ChangH,WangF,YangZ,SunB,ChenZe*.EfficacyofinactivatedvaccineagainstH5N1influenzavirusinfectioninmicewithtype1diabetes.Vaccine.2010Mar24;28(15)：2775-81
　　SuiZ,ChenQ,WuR,ZhangH,ZhengM,WangH,ChenZe*.Cross-protectionagainstinfluenzavirusinfectionbyintranasaladministrationofM2-basedvaccinewithchitosanasanadjuvant.ArchVirol.ArchVirol.2010Apr;155(4):535-44
　　LiangXF,WangHQ,WangJZ,FangHH,WuJ,ZhuFC,LiRC,XiaSL,ZhaoYL,LiFJ,YanSH,YinWD,AnK,FengDJ,CuiXL,QiFC,JuCJ,ZhangYH,GuoZJ,ChenPY,ChenZ,YanKM,WangY.Safetyandimmunogenicityof2009pandemicinfluenzaAH1N1vaccinesinChina:amulticentre,double-blind,randomised,placebo-controlledtrial.Lancet.2010Jan2;375(9708):56-66.